This recording from Thursday, 27 November 2025 features leading international experts who discuss the importance of accurate assays for diagnosing AQP4-NMOSD and MOGAD, explore regional assay availability, and share innovative approaches for sample testing and disease monitoring.

Agenda:

• Welcome and introduction – The importance of having accurate assays for the diagnosis of AQP4-NMOSD and MOGAD - Sara Samadzadeh (Germany/Denmark)

• Current assays available for testing (assay availability survey) - Patrick Waters (UK)

• Q&A – Regional perspectives on assay availability- Adriana Casallas Vanegas (Colombia/Spain) & Sanja Glucevic (Montenegro)

• Sample types and testing approaches: CSF vs. serum for AQP4-NMOSD and MOGAD - Sara Mariotto (Italy) - Other approaches and experiences (Rapid IDOT)

• Other approaches and experiences (Rapid IDOT) - Rui Li (China) 

• Limited availability of Live CBA for AQP4-IgG testing in LATAM countries - Vinícius Boldrini (Brazil)

• Closing and wrap-up